Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 4/20 | 0.63 |
| ▸ | TUBB | P07437 | 4/20 | 0.63 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.63 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.63 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.63 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.63 |
| ▸ | TUBB3 | Q13509 | 4/20 | 0.63 |
| ▸ | TUBB2A | Q13885 | 4/20 | 0.63 |
| ▸ | TUBB8 | Q3ZCM7 | 4/20 | 0.63 |
| ▸ | TUBA3E | Q6PEY2 | 4/20 | 0.63 |
| ▸ | TUBA1A | Q71U36 | 4/20 | 0.63 |
| ▸ | TUBA1C | Q9BQE3 | 4/20 | 0.63 |
| ▸ | TUBB6 | Q9BUF5 | 4/20 | 0.63 |
| ▸ | TUBB2B | Q9BVA1 | 4/20 | 0.63 |
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.63 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.59 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.59 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.59 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.59 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29934781 | 1.00 | TUBB4A (0.63) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL30008021 | 1.00 | TUBB4A (0.63) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29449679 | 1.00 | TUBB4A (0.63) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL9089602 | 0.92 | CALM1 (0.64) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL20682611 | 0.88 | POLB (0.68) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL18563067 | 0.84 | CALM1 (0.66) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL30007868 | 0.84 | CALM1 (0.66) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL30079962 | 0.84 | TUBB4A (0.74) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29286367 | 0.84 | TUBB4A (0.74) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL11504708 | 0.83 | TUBB4A (0.69) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022236789-A1 | EXTRACT OF DENDROBIUM SINENSE, DENDROBIUM DENSIFLORUM, OR DENDROBIUM BENSONIAE, AND APPLICATION OF MAIN COMPONENTS THEREOF AS ANTI-INFLAMMATORY FORMULATION | 中国热带农业科学院热带生物技术研究所 | 2022-11-17 | — | — | WO | claimed |
| CN-113633718-A | Extract of Dendrobium huoshanense, Dendrobii florida or Dendrobium nobile and application of main component of extract as anti-inflammatory preparation | 中国热带农业科学院热带生物技术研究所 | 2021-11-12 | — | — | CN | claimed |
| WO-2022236789-A1 | EXTRACT OF DENDROBIUM SINENSE, DENDROBIUM DENSIFLORUM, OR DENDROBIUM BENSONIAE, AND APPLICATION OF MAIN COMPONENTS THEREOF AS ANTI-INFLAMMATORY FORMULATION | 中国热带农业科学院热带生物技术研究所 | 2022-11-17 | — | — | WO | disclosed |
| WO-2022236789-A1 | EXTRACT OF DENDROBIUM SINENSE, DENDROBIUM DENSIFLORUM, OR DENDROBIUM BENSONIAE, AND APPLICATION OF MAIN COMPONENTS THEREOF AS ANTI-INFLAMMATORY FORMULATION | 中国热带农业科学院热带生物技术研究所 | 2022-11-17 | — | — | WO | disclosed |
| CN-109952286-B | Skin protection composition based on dendrobe components | 香港浸会大学 | 2022-03-22 | — | — | CN | disclosed |
| CN-113633718-A | Extract of Dendrobium huoshanense, Dendrobii florida or Dendrobium nobile and application of main component of extract as anti-inflammatory preparation | 中国热带农业科学院热带生物技术研究所 | 2021-11-12 | — | — | CN | disclosed |
| CN-110698328-A | Method for using dihydroresveratrol or stilbene derivatives and/or chemical variants thereof as antimicrobial agents | 香港浸会大学 | 2020-01-17 | — | — | CN | disclosed |
| US-10351500-B2 | Method of using of dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants as antimicrobial agents | HONG KONG BAPTIST UNIVERSITY (HK) | 2019-07-16 | — | — | US | disclosed |
| CN-109952286-A | Skin protection composition based on Dendrobium ingredient | 香港浸会大学 | 2019-06-28 | — | — | CN | disclosed |
| US-10188590-B2 | Skin-protection composition containing Dendrobium-based ingredients | HONG KONG BAPTIST UNIVERSITY (HK) | 2019-01-29 | — | — | US | disclosed |
| US-10017442-B2 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatment of tumorous pathologies | HONG KONG BAPTIST UNIVERSITY (HK) | 2018-07-10 | — | — | US | disclosed |
| US-20170290782-A1 | Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | HONG KONG BAPTIST UNIVERSITY (HK) | 2017-10-12 | — | — | US | disclosed |
| US-20170290782-A1 | Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | HONG KONG BAPTIST UNIVERSITY (HK) | 2017-10-12 | — | — | US | disclosed |
| US-9738581-B2 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | HONG KONG BAPTIST UNIVERSITY (HK) | 2017-08-22 | — | — | US | disclosed |
| US-9738581-B2 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | HONG KONG BAPTIST UNIVERSITY (HK) | 2017-08-22 | — | — | US | disclosed |
| US-20170057896-A1 | Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
| US-20170057906-A1 | SKIN-PROTECTION COMPOSITION CONTAINING DENDROBIUM-BASED INGREDIENTS | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
| US-20170057906-A1 | SKIN-PROTECTION COMPOSITION CONTAINING DENDROBIUM-BASED INGREDIENTS | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
| US-20170057906-A1 | SKIN-PROTECTION COMPOSITION CONTAINING DENDROBIUM-BASED INGREDIENTS | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
| US-20170057896-A1 | Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170057906-A1 | SKIN-PROTECTION COMPOSITION CONTAINING DENDROBIUM-BASED INGREDIENTS | TYR, MC1R, SYMPK | TUBB4A 901/4885TUBB 575/4885TUBA3C 3824/4885 |
| US-10017442-B2 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatment of tumorous pathologies | VHL, ETV1, DHODH | TUBB4A 2571/4885TUBB 3105/4885TUBA3C 3944/4885 |
| US-10188590-B2 | Skin-protection composition containing Dendrobium-based ingredients | TYR, MC1R, SYMPK | TUBB4A 1115/4885TUBB 729/4885TUBA3C 4087/4885 |
| US-20170057896-A1 | Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | RNASE1, KRAS, DPP3 | TUBB4A 3202/4885TUBB 4160/4885TUBA3C 3294/4885 |
| US-10351500-B2 | Method of using of dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants as antimicrobial agents | DPM1, SUCLG1, VDR | TUBB4A 383/4885TUBB 194/4885TUBA3C 903/4885 |
| US-20170290782-A1 | Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | RNASE1, IAPP, DPP4 | TUBB4A 3710/4885TUBB 4432/4885TUBA3C 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.